Patents by Inventor Ana Jimenez

Ana Jimenez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12077472
    Abstract: A defoamed aqueous composition including 5 to 75 weight-% of at least one anionic polymer, 0.05 to 5 weight-% of at least one water insoluble liquid defoamer and 0.005 to 3 weight-% of at least one polysaccharide, based on 100 weight-% of the composition. The composition gives predictable air content in non-air entrained and air-entrained mortar and concrete.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: September 3, 2024
    Assignee: SIKA TECHNOLOGY AG
    Inventor: Ana Jimenez
  • Publication number: 20240262104
    Abstract: A device (1) for parallel dispensing a print medium (10) onto a substrate, in particular for producing one or more conductor tracks on a semiconductor substrate, having a printing unit (6), which includes a plurality of dispenser nozzles for simultaneous discharge of the print medium (10), and having a drive (5), which is configured to generate a relative movement between the printing unit (6) and the substrate (4) in a movement direction (7). At least first usnd second dispenser nozzles are arranged spaced apart from one another transversely in relation to the movement direction (7). The first dispenser nozzle and a third dispenser nozzle are arranged spaced apart from one another along a common first longitudinal axis at a first nozzle spacing, and the first longitudinal axis runs parallel to the movement direction (7).
    Type: Application
    Filed: October 28, 2021
    Publication date: August 8, 2024
    Applicant: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Maximilian POSPISCHIL, Martin KUCHLER, Martin BREITENBÜCHER, Tim RIEBE, Sebastian TEPNER, Florian CLEMENT, Maximilian WEIL, Katharina GENSOWKI, Ana JIMENEZ CARDOZO
  • Publication number: 20240180162
    Abstract: A hybrid material includes a protein matrix and nanoparticles (NPs) of a type of Cu; a preparation method thereof; and the uses thereof. The hybrid material displays activity that inhibits SARS-CoV-2 proteins, which makes it usable as a biocidal agent and as an agent for coating and disinfecting materials selected from metal, paper, textiles and approved surgical face masks.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 6, 2024
    Inventors: Jose Miguel PALOMO CARMONA, Noelia LOSADA GARCÍA, Olga ABIAN FRANCO, Adrián VELÁZQUEZ CAMPOY, David ORTEGA ALARCÓN, Ana JIMÉNEZ ALESANCO, Laura CEBALLOS LAITA
  • Publication number: 20230322622
    Abstract: Methods for the treatment of non-hardened cement compositions, especially returned concrete, and admixtures suitable to be used in such methods. The admixtures include modified starch and a sugar. Also, solid granules obtained by the methods and fresh concrete or mortar utilizing solid granules thus obtained.
    Type: Application
    Filed: March 25, 2022
    Publication date: October 12, 2023
    Applicant: SIKA TECHNOLOGY AG
    Inventors: Ana JIMENEZ, Svetlana LEVITINA, Kyle GOLDHAMMER
  • Publication number: 20210300823
    Abstract: A defoamed aqueous composition including 5 to 75 weight-% of at least one anionic polymer, 0.05 to 5 weight-% of at least one water insoluble liquid defoamer and 0.005 to 3 weight-% of at least one polysaccharide, based on 100 weight-% of the composition. The composition gives predictable air content in non-air entrained and air-entrained mortar and concrete.
    Type: Application
    Filed: July 10, 2019
    Publication date: September 30, 2021
    Applicant: Sika Technology AG
    Inventor: Ana JIMENEZ
  • Patent number: 9000047
    Abstract: The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the ?-amyloid peptide.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: April 7, 2015
    Assignee: Farmalider, S.A.
    Inventors: Pilar Navarro Medrano, Elisabet Gregori Puigjane, Marisol Montolio Del Olmo, Ana Jimenez Redondo, Jordi Mestres Lopez
  • Publication number: 20130065966
    Abstract: The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the ?-amyloid peptide.
    Type: Application
    Filed: May 24, 2010
    Publication date: March 14, 2013
    Applicant: FARMALIDER, S.A.
    Inventors: Pilar Navarro Medrano, Elisabet Gregori Puigjane, Marisol Montolio Del Olmo, Ana Jimenez Redondo, Jordi Mestres Lopez
  • Publication number: 20120046368
    Abstract: Process for purifying 3,4-dihydroxyphenylglycol (DHPG) from any part of the plant, from the products or by-products derived from olive trees or any other vegetable product of the families Oleaceae, Orobanchaceae, Plantaginaceae, Compositae, Lamiaceae, Acanthaceae and/or Scrophulariaceae, and which comprises 1 or more steps wherein the initial product is introduced into at least one ion-exchange resin column, and in potentially subsequent steps the product eluted in the preceding column is introduced into an ion-exchange resin and/or a non-ionic adsorption resin column. Moreover, it relates to the DHPG extract obtainable by means of the process disclosed and to the applications thereof.
    Type: Application
    Filed: November 30, 2009
    Publication date: February 23, 2012
    Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
    Inventors: Juan Fernández-Bolaños Guzmán, Rafael Guillén Bejarano, Ana Jimenez Araujo, Rocío Rodríguez Arcos, Guillermo Rodríguez Gutiérrez, Antonio Lama Muñoz
  • Publication number: 20070270365
    Abstract: Sequences and protocols for treatment of eye conditions by use of RNA interference are disclosed. Target genes are selected from those responsible for aqueous flow or aqueous outflow, while particularly preferred conditions to be treated include glaucoma and uveitis.
    Type: Application
    Filed: August 23, 2005
    Publication date: November 22, 2007
    Applicant: Sylentis S.A.
    Inventors: Ana Jimenez, Angela Sesto, Jose Roman, Irene Gascon, Gonzalo Gonzalez de Buitrago
  • Publication number: 20060234970
    Abstract: The present invention relates to methods and compositions that decrease intraocular pressure (IOP) of the eye. The compositions of the invention comprise short interfering nucleic acid molecules (siNA) including, but not limited to, siRNA that decrease expression of genes associated with production or drainage of intraocular fluid. The compositions of the invention can be used in the preparation of a medicament for the treatment of an eye conditions displaying increased IOP such as glaucoma, infection, inflammation, uveitis, and diabetic retinopathy. The methods of the invention comprise the administration to a patient in need thereof an effective amount of one or more siNAs of the invention.
    Type: Application
    Filed: February 22, 2006
    Publication date: October 19, 2006
    Inventors: Ana Jimenez, Angela Sesto, Irene Gascon, Jose Roman
  • Patent number: 6849770
    Abstract: The present invention relates to a method for obtaining purified hydroxytyrosol from products and by-products derived from the olive tree by means of two-step chromatographic treatment. The invention uses a non-activated ion exchange resin chromatographic method, followed by a second treatment on an XAD-type absorbent non-ionic resin which concentrates and completely purifies the hydroxytyrosol by means of elution with a methanol or ethanol:water dissolution (from 30 to 33%). The method of the invention can also be applied to two-phase pomaces, three-phase pomaces and stones if they are subjected to a steam explosion process.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: February 1, 2005
    Assignee: Consejo Superior de Investigaciones Cientificas
    Inventors: Juan Fernandez-Bolaños Guzman, Antonia Heredia Moreno, Guillermo Rodriguez Gutierrez, Rocío Rodriguez Arcos, Ana Jimenez Araujo, Rafael Guillen Bejarano
  • Publication number: 20040102657
    Abstract: The present invention relates to a method for obtaining purified hydroxytyrosol from products and by-products derived from the olive tree by means of two-step chromatographic treatment. The invention uses a non-activated ion exchange resin chromatographic method, followed by a second treatment on an XAD-type absorbent non-ionic resin which concentrates and completely purifies the hydroxytyrosol by means of elution with a methanol or ethanol:water dissolution (from 30 to 33%). The method of the invention can also be applied to two-phase pomaces, three-phase pomaces and stones if they are subjected to a steam explosion process.
    Type: Application
    Filed: August 13, 2003
    Publication date: May 27, 2004
    Inventors: Juan Fernandez-Bolanos Guzman, Antonia Heredia Moreno, Guillermo Rodriguez Gutierrez, Rocio Rodriguez Arcos, Ana Jimenez Araujo, Rafael Guillen Bejarano